Lloyd Paul Aiello, MD, PhD
Lloyd Paul Aiello, MD, PhD
Professor of Ophthalmology, Joslin Diabetes Center, Harvard Medical School
Verified email at joslin.harvard.edu
Title
Cited by
Cited by
Year
Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders
LP Aiello, RL Avery, PG Arrigg, BA Keyt, HD Jampel, ST Shah, ...
New England Journal of Medicine 331 (22), 1480-1487, 1994
44291994
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins
LP Aiello, EA Pierce, ED Foley, H Takagi, H Chen, L Riddle, N Ferrara, ...
Proceedings of the National Academy of Sciences 92 (23), 10457-10461, 1995
14931995
Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema
MJ Elman, LP Aiello, RW Beck, NM Bressler, SB Bressler, AR Edwards, ...
Ophthalmology 117 (6), 1064-1077. e35, 2010
14892010
Retinopathy in diabetes
DS Fong, L Aiello, TW Gardner, GL King, G Blankenship, JD Cavallerano, ...
Diabetes care 27 (suppl 1), s84-s87, 2004
11742004
Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization
EA Pierce, RL Avery, ED Foley, LP Aiello, LE Smith
Proceedings of the National Academy of Sciences 92 (3), 905-909, 1995
11691995
Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.
JA Wells, AR Glassman, AR Ayala, LM Jampol, LP Aiello, AN Antoszyk, ...
The New England journal of medicine 372 (13), 1193-1203, 2015
10052015
Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition
K Miyamoto, S Khosrof, SE Bursell, R Rohan, T Murata, AC Clermont, ...
Proceedings of the National Academy of Sciences 96 (19), 10836-10841, 1999
8381999
Vascular endothelial growth factor–induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective β-isoform–selective inhibitor
LP Aiello, SE Bursell, A Clermont, E Duh, H Ishii, C Takagi, F Mori, ...
Diabetes 46 (9), 1473-1480, 1997
8381997
Hypoxic regulation of vascular endothelial growth factor in retinal cells
LP Aiello, JM Northrup, BA Keyt, H Takagi, MA Iwamoto
Archives of ophthalmology 113 (12), 1538-1544, 1995
7361995
Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth.
P Xia, LP Aiello, H Ishii, ZY Jiang, DJ Park, GS Robinson, H Takagi, ...
The Journal of clinical investigation 98 (9), 2018-2026, 1996
6871996
A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema
Diabetic Retinopathy Clinical Research Network
Ophthalmology 115 (9), 1447-1459. e10, 2008
6722008
Risks of intravitreous injection: a comprehensive review
RD Jager, LP Aiello, SC Patel, ET Cunningham Jr
Retina 24 (5), 676-698, 2004
6422004
Relationship between optical coherence tomography–measured central retinal thickness and visual acuity in diabetic macular edema
Diabetic Retinopathy Clinical Research Network
Ophthalmology 114 (3), 525-536, 2007
5742007
Residual insulin production and pancreatic β-cell turnover after 50 years of diabetes: Joslin Medalist Study
HA Keenan, JK Sun, J Levine, A Doria, LP Aiello, G Eisenbarth, ...
Diabetes 59 (11), 2846-2853, 2010
4682010
Cost-effectiveness of detecting and treating diabetic retinopathy
M Lambert
Annals of internal medicine 125 (11), 939, 1996
4611996
Evolving guidelines for intravitreous injections
LP Aiello, AJ Brucker, S Chang, JR EMMETT T CUNNINGHAM, ...
Retina 24 (5), S3-S19, 2004
4592004
Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth
EJ Duh, HS Yang, I Suzuma, M Miyagi, E Youngman, K Mori, M Katai, ...
Investigative ophthalmology & visual science 43 (3), 821-829, 2002
4442002
Vascular endothelial growth factor and diabetes: the agonist versus antagonist paradox.
E Duh, LP Aiello
Diabetes 48 (10), 1899-1906, 1999
4271999
Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: three-year randomized trial results
MJ Elman, H Qin, LP Aiello, RW Beck, NM Bressler, FL Ferris III, ...
Ophthalmology 119 (11), 2312-2318, 2012
4242012
Activation of PKC-δ and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy
P Geraldes, J Hiraoka-Yamamoto, M Matsumoto, A Clermont, M Leitges, ...
Nature medicine 15 (11), 1298-1306, 2009
4132009
The system can't perform the operation now. Try again later.
Articles 1–20